Drawing for KERRAPULSE

USPTO serial 88065271

KERRAPULSE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KERRAPULSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pamela B. Huff

Pamela B. Huff SCHWEGMAN LUNDBERG & WOESSNER, P.A.P.O. BOX 2938MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; medicated, sanitary or disinfecting preparations for the treatment of the feet, body, and skin diseases; medicinal and therapeutic preparations for the cleaning and debridement of wounds; disinfectant preparations for skin care being all purpose disinfectants, antiseptics, antifungal preparations; pharmaceutical preparations and medicated skin preparations for the treatment of scars and scars related skin conditions; medicated or pharmaceutical products for corns and chilblains; medicated preparations for curing ingrown toe-nails; medicated pads for the prevention of inflammation of the toes and of the thickening of skin calluses; wound dressings and materials for wound dressings, namely, absorbent pads for skin wounds; medical wound dressings for use in cleansing wounds, exfoliating skin and wounds and removing debris from skin and wounds; bandages and dressings for the treatment of skin wounds, burns, diabetic ulcers, pressure ulcers, surgical wounds, vascular and circulatory system related skin diseases; non-supportive bandages in the shape of a boot for dressing foot wounds; medical plasters for protecting, cushioning and moisturising corns and blisters; medicated corn and bunion pads and insoles; bandages and dressings for the treatment of the skin impregnated with anti-fungal preparations and antimicrobial preparations and substances; dressings for the management of exudate from wounds; medical dressings; medical materials for dressings, namely, plasters, plaster rings, rings for corns; adhesive plasters for medical purposes; non-woven polyester medical dressings; non-woven medical dressings; foam wound dressings; absorptive foam dressings and pads for wound care; adhesive non-woven fabric for application and fixation of dressings; self-adhesive dressings; surgical dressings; gauze for dressings; bandages for dressings; pharmaceutical preparations for the treatment of wounds and skin, namely, foils, meshes, compresses, permeable plastic films; medicated compresses; medicated cleansing pads for the skin; medicated absorbent pads for skin wounds; dressings and pads incorporating anti-fungal substances; dressings and pads incorporating antimicrobial substances; anti-fungal sprays; antibacterial sprays; bandages for skin wounds; all-purpose disinfectants; antiseptic preparations; sanitizing wipes; anti-fungal preparations; antimicrobial preparations for inhibiting and preventing bacteria; antimicrobials for dermatologic use; medical materials for dressings, namely, gauze, foam pads, hydrogel pads, hydrocolloid pads, medical adhesive and non-adhesive tape for retention and fixation of dressings, non-woven fabric for application and fixation of dressings; disinfectant preparations and antiseptic products, namely, wipes, tissues, sponges impregnated with disinfectant, sanitizing, or antiseptic preparationsACTIVE—
009Scientific instruments and apparatus for storing, relaying, tracking, measuring and displaying biometric dataACTIVE—
010Medical, orthotic, and orthopaedic devices for closing wounds; wearable medical devices, namely, devices for enhancing blood flow for closing wounds; electronic monitoring instruments for monitoring the stimulation of muscles to enhance blood flow for medical use; medical instruments and apparatus for storing, relaying, tracking, measuring, and displaying biometric data; medical devices for measuring, tracking, and improving blood and lymphatic circulation in the limbs or tissues; electronic stimulation apparatus for administering an electrical stimulus for increasing blood flow for wound healing purposes; compression bandages for dressings; elastic bandages for dressings; support bandages for dressingsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 12, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 12, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2020EX2GSOU EXTENSION 2 GRANTED—
Jul 27, 2020EXT2SOU EXTENSION 2 FILED—
Jul 27, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 9, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 9, 2020EXT1SOU EXTENSION 1 FILED—
Mar 9, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 2, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 10, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 11, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jun 7, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 3, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 29, 2019ALIEASSIGNED TO LIE—
May 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2018DOCKASSIGNED TO EXAMINER—
Aug 10, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance